Daniel Deykin

15.1k total citations · 5 hit papers
157 papers, 11.8k citations indexed

About

Daniel Deykin is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Surgery. According to data from OpenAlex, Daniel Deykin has authored 157 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 36 papers in Hematology and 33 papers in Surgery. Recurrent topics in Daniel Deykin's work include Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Venous Thromboembolism Diagnosis and Management (25 papers) and Eicosanoids and Hypertension Pharmacology (22 papers). Daniel Deykin is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Venous Thromboembolism Diagnosis and Management (25 papers) and Eicosanoids and Hypertension Pharmacology (22 papers). Daniel Deykin collaborates with scholars based in United States, Australia and Canada. Daniel Deykin's co-authors include James E. Dalen, L. Poller, Jack Ansell, Jack Hirsh, Henry I. Bussey, Ruth M. Kramer, Susan Rittenhouse-Simmons, David R. Anderson, Christine Balko and S L Hong and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Daniel Deykin

157 papers receiving 10.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

2001 1.2k citations J. Hirsh, James E. Dalen et al. CHEST Journal profile →
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation

1992 850 citations Michael D. Ezekowitz, Samuel L. Bridgers et al. New England Journal of Medicine profile →
Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura

1982 845 citations Daniel Deykin et al. New England Journal of Medicine profile →
Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety

1992 435 citations Jack Hirsh, James E. Dalen et al. CHEST Journal profile →
Management of Heparin Therapy

1975 359 citations Daniel Deykin et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Deykin United States	55	4.0k	2.5k	2.5k	2.3k	1.9k	157	11.8k
Desmond J. Fitzgerald Ireland	53	4.0k 1.0×	1.2k 0.5×	2.0k 0.8×	2.2k 0.9×	1.9k 1.0×	164	10.1k
Giovanni Davı̀ Italy	61	5.0k 1.2×	1.4k 0.5×	3.0k 1.2×	1.3k 0.6×	1.8k 0.9×	219	13.5k
George J. Miller United Kingdom	56	2.9k 0.7×	654 0.3×	3.1k 1.3×	2.2k 1.0×	1.1k 0.6×	181	12.4k
Marco Cattaneo Italy	67	5.6k 1.4×	3.4k 1.3×	2.7k 1.1×	6.1k 2.6×	1.3k 0.7×	317	14.9k
Francesco Violi Italy	78	5.5k 1.4×	1.6k 0.6×	3.9k 1.6×	1.5k 0.6×	2.9k 1.5×	542	20.8k
Pasquale Pignatelli Italy	57	3.5k 0.9×	971 0.4×	1.7k 0.7×	812 0.3×	2.0k 1.1×	349	11.0k
Jane E. Freedman United States	54	2.2k 0.5×	583 0.2×	1.0k 0.4×	1.6k 0.7×	3.3k 1.7×	175	10.2k
Stefano De Servi Italy	50	9.4k 2.4×	1.5k 0.6×	5.3k 2.1×	369 0.2×	2.7k 1.4×	395	14.4k
Harald Darius Germany	43	11.8k 3.0×	4.5k 1.8×	5.2k 2.1×	613 0.3×	807 0.4×	202	17.9k
Ranjan Chakrabarti United Kingdom	41	1.3k 0.3×	496 0.2×	1.1k 0.4×	1.3k 0.6×	1.2k 0.6×	117	6.8k

Countries citing papers authored by Daniel Deykin

Since Specialization

Citations

This map shows the geographic impact of Daniel Deykin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Deykin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Deykin more than expected).

Fields of papers citing papers by Daniel Deykin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Deykin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Deykin. The network helps show where Daniel Deykin may publish in the future.

Co-authorship network of co-authors of Daniel Deykin

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Deykin. A scholar is included among the top collaborators of Daniel Deykin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Deykin. Daniel Deykin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ansell, Jack, Jack Hirsh, James E. Dalen, et al.. (2001). Managing Oral Anticoagulant Therapy. CHEST Journal. 119(1). 22S–38S. 446 indexed citations

Hirsh, J., James E. Dalen, David R. Anderson, et al.. (2001). Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range. CHEST Journal. 119(1). 8S–21S. 1184 indexed citations breakdown →

Henderson, William G., John G. Demakis, Stephan D. Fihn, et al.. (1998). Cooperative Studies in Health Services Research in the Department of Veterans Affairs. Controlled Clinical Trials. 19(2). 134–148. 9 indexed citations

Ashton, Carol M., et al.. (1996). A State-of-the-Art Conference on Databases Pertaining to Veterans' Health. Medical Care. 34(Supplement). 1–8. 8 indexed citations

Rockhold, Frank W., Gregory G. Enas, Peter B. Meier, et al.. (1993). Discussion: Frank W Rockhold and G Enas, data monitoring and interim analyses in the pharmaceutical industry: Ethical and logistical considerations: George W Williams et al, monitoring of clinical trials and interim analyses from a drug sponsor's point of view. Statistics in Medicine. 12. 493–495. 1 indexed citations

Pritzker, Carole R., et al.. (1993). Porcine aortic endothelial cell membranes contain a LPAF:CoA-independent transacylase. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1145(1). 113–118. 4 indexed citations

Ezekowitz, Michael D., Samuel L. Bridgers, K James, et al.. (1992). Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation. New England Journal of Medicine. 327(20). 1406–1412. 850 indexed citations breakdown →

Cairns, John, Lawrence S. Cohen, Theodore Colton, et al.. (1991). Issues in the early termination of the aspirin component of the physicians' health study. Annals of Epidemiology. 1(5). 395–405. 19 indexed citations

Ring, Michael, John J. Vecchione, Louis D. Fiore, et al.. (1991). Detection of intracoronary fibrin degradation after coronary balloon angioplasty. The American Journal of Cardiology. 67(16). 1330–1334. 11 indexed citations

10.

Deykin, Daniel. (1990). Antithrombotic therapy in historical perspective. The American Journal of Cardiology. 65(6). C2–C6. 6 indexed citations

11.

Tesfamariam, Belay, Michael L. Brown, Daniel Deykin, & Richard A. Cohen. (1990). Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta.. Journal of Clinical Investigation. 85(3). 929–932. 298 indexed citations

12.

Brown, Michael L., et al.. (1988). Elevated glucose alters eicosanoid release from porcine aortic endothelial cells.. Journal of Clinical Investigation. 82(6). 2136–2141. 40 indexed citations

13.

Kramer, Ruth M., Joseph A. Jakubowski, & Daniel Deykin. (1988). Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 959(3). 269–279. 69 indexed citations

14.

Rocklin, Ross E., et al.. (1988). Altered arachidonic acid metabolism and platelet size in atopic subjects. Clinical Immunology and Immunopathology. 46(3). 352–359. 21 indexed citations

15.

Deykin, Daniel. (1987). Anticoagulants in Acute Myocardial Infarction. PubMed. 214. 231–241. 2 indexed citations

16.

Brown, Michael L., et al.. (1987). Ionophore-induced metabolism of phospholipids and eicosanoid production in porcine aortic endothelial cells: selective release of arachidonic acid from diacyl and ether phospholipids. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 921(2). 159–166. 37 indexed citations

17.

Jakubowski, Joseph A., et al.. (1985). Cumulative antiplatelet effect of low‐dose enteric coated aspirin. British Journal of Haematology. 60(4). 635–642. 83 indexed citations

18.

Deykin, Daniel, et al.. (1976). The effect of thrombin on the uptake and transformation of arachidonic acid by human platelets. American Journal of Hematology. 1(1). 59–70. 28 indexed citations

19.

Deykin, Daniel. (1969). The Use of Heparin. New England Journal of Medicine. 280(17). 937–938. 29 indexed citations

20.

Deykin, Daniel & Stanford Wessler. (1964). Activation Product, Factor IX, Serum Thrombotic Accelerator Activity, and Serum-induced Thrombosis*. Journal of Clinical Investigation. 43(2). 160–166. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact